- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT04817280
COVID-19 in Polish Ice Swimmers. (ICE)
Influence of Ice Swimming on Hardening Against SARS-CoV-2 and Influence of AB0 Rh Blood Type on Viral Resistance in Polish Ice Swimmers.
Studie Overzicht
Toestand
Interventie / Behandeling
Gedetailleerde beschrijving
The research tool is an original questionnaire compiled by a team of experts conducting the study. The survey includes questions about sociodemographic data, such as age and gender and blood type in AB0 system with Rh factor, and questions about the frequency of ice swimming, the duration of a single session, and since when respondents have been ice swimming. There was also a question about the respondents' compliance with the restrictions and recommendations related to the pandemic and contacts with people with confirmed SARS-CoV-2 infection. In the survey, researchers ask about the infectious symptoms experienced during the pandemic and about being diagnosed with COVID-19 or its exclusion. People who have been ill are asked about the place of treatment.
The questionnaires are collected in traditional form, on the Internet and as scans of documents. Each survey was completely anonymous. The obtained statistical data will be compared with official data on new COVID-19 cases and recoveries at the same time. Official data are published by the Ministry of Health and earlier also by Sanitary and Epidemiological Stations. The main aim of the study was to determine whether ice swimming also increases resistance to SARS-CoV-2 and COVID-19.
Studietype
Inschrijving (Werkelijk)
Contacten en locaties
Studie Locaties
-
-
Dolny Slask
-
Wrocław, Dolny Slask, Polen, 51-618
- Department of Public Health at Wroclaw Medical University
-
-
Lubuskie
-
Gorzów Wielkopolski, Lubuskie, Polen, 66-400
- Department of Radiotherapy of Multidisciplinary Provincial Hospital
-
Zielona Góra, Lubuskie, Polen, 65-031
- Treasury Medical Company
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
- Kind
- Volwassen
- Oudere volwassene
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Bemonsteringsmethode
Studie Bevolking
Beschrijving
Inclusion Criteria:
- ice swimmers
Exclusion Criteria:
- not active ice swimmers
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
Cohorten en interventies
Groep / Cohort |
Interventie / Behandeling |
|---|---|
|
Ice Swimmers Group.
No intervention.
Data obtained from Polish ice swimmers reported by them retrospectively in the questionnaire.
|
The intervention is not made in the course of a research study.
Ice swimming has been introduced earlier by a given group.
The group was made up of people who already swim in ice.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Assessment of the incidence of COVID-19 among ice swimmers compared to the general population.
Tijdsspanne: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of asymptomatic SARS-CoV-2 infection among ice swimmers compared to the general population.
Tijdsspanne: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of occurrence of particular symptoms of SARS-CoV-2 infection among ice swimmers compared to the general population.
Tijdsspanne: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the frequency of COVID-19 treatment in an outpatient, inpatient and intensive care unit among ice swimmers compared to the general population.
Tijdsspanne: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
|
Assessment of the impact of parameters and ice swimming strategies on the likelihood of developing COVID-19, the occurrence of individual symptoms of the disease and the severity of its course.
Tijdsspanne: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
|
Assessment of the influence of blood group on susceptibility to SARS-CoV-2 infection among ice swimmers.
Tijdsspanne: 47 days.
|
Inference from data obtained from surveys collected among ice swimmers.
|
47 days.
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Assessment of the immunity of the ice swimmer's immune system compared to the general population.
Tijdsspanne: 47 days.
|
Comparison of the data obtained from surveys collected among ice swimmers with the data published in official channels for the general population during this period.
|
47 days.
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Studie directeur: Sylwia Sulimiera Michalak, MD, PhD, Department of Pharmacology and Toxicology, Medical University of Zielona Gora
- Studie directeur: Edyta Wolny-Rokicka, MD, PhD, Department and Center of Radiotherapy, Multidisciplinary Provincial Hospital in Gorzow Wielkopolski
- Studie stoel: Andrzej Tukiendorf, Prof., Department of Public Health, Wroclaw Medical University
- Hoofdonderzoeker: Lukasz K Wysoczanski, MD, Department of Family Medicine, Wroclaw Medical University
- Hoofdonderzoeker: Paulina N Wysoczanska, MD, Department of Family Medicine, Wroclaw Medical University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
- Pathologische processen
- Coronavirus-infecties
- Coronaviridae-infecties
- Nidovirales-infecties
- RNA-virusinfecties
- Virusziekten
- Infecties
- Luchtweginfecties
- Ziekten van de luchtwegen
- Longontsteking, viraal
- Longontsteking
- Longziekten
- Ziekte attributen
- Veranderingen in lichaamstemperatuur
- Ernstig acuut respiratoir syndroom
- COVID-19
- Hypothermie
- Ziekteresistentie
Andere studie-ID-nummers
- KB-03/139/2021
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .